- Home
- TAK vs CVNA Comparison
TAK vs CVNA Comparison
Compare TAK & CVNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TAK | CVNA |
|---|---|---|
| Founded | 1781 | 2012 |
| Country | Japan | United States |
| Employees | 47455 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.4B | 47.1B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | TAK | CVNA |
|---|---|---|
| Price | $16.39 | $69.50 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 24 |
| Target Price | N/A | ★ $439.67 |
| AVG Volume (30 Days) | 2.6M | ★ 9.0M |
| Earning Date | 05-13-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.24% | N/A |
| EPS Growth | N/A | ★ 431.45 |
| EPS | N/A | ★ 8.45 |
| Revenue | N/A | ★ $20,322,000,000.00 |
| Revenue This Year | $0.16 | $34.66 |
| Revenue Next Year | $1.22 | $23.38 |
| P/E Ratio | $41.25 | ★ $7.70 |
| Revenue Growth | N/A | ★ 48.63 |
| 52 Week Low | $12.99 | $61.03 |
| 52 Week High | $18.90 | $486.89 |
Technical Indicators
Market Signals| Indicator | TAK | CVNA |
|---|---|---|
| Relative Strength Index (RSI) | 53.25 | 39.58 |
| Support Level | $16.24 | $61.60 |
| Resistance Level | $16.48 | $73.32 |
| Average True Range (ATR) | 0.21 | 3.73 |
| MACD | 0.06 | 4.28 |
| Stochastic Oscillator | 51.94 | 78.81 |
Price Performance
Historical ComparisonAbout TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
About CVNA Carvana Co.
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage. The foundation of the business is retail vehicle unit sales. This drives the majority of the revenue and allows the company to capture additional revenue streams associated with financing, VSCs, auto insurance and GAP waiver coverage, as well as trade-in vehicles.